Ten-Year Progression-Free and Overall Survival in Patients With Unresectable or Metastatic GI Stromal Tumors: Long-Term Analysis of the European Organisation for Research and Treatment of Cancer, Italian Sarcoma Group, and Australasian Gastrointestinal Trials Group Intergroup Phase III Randomized Trial on Imatinib at Two Dose Levels.
J Clin Oncol
; 35(15): 1713-1720, 2017 May 20.
Article
en En
| MEDLINE
| ID: mdl-28362562
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Tumores del Estroma Gastrointestinal
/
Mesilato de Imatinib
/
Neoplasias Gastrointestinales
/
Antineoplásicos
Tipo de estudio:
Clinical_trials
/
Prognostic_studies
Límite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
J Clin Oncol
Año:
2017
Tipo del documento:
Article